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Abstract
This paper reports survey findings on the Swiss public’s willingness, attitudes, and concerns
regarding personalized health research participation by providing health information and
biological material. The survey reached a sample of 15,106 Swiss residents, from which we
received 5,156 responses (34.1% response rate). The majority of respondents were aware
of research using human biological samples (71.0%) and held a positive opinion towards
this type of research (62.4%). Of all respondents, 53.6% indicated that they would be willing
to participate in a personalized health research project. Willingness to participate was higher
in younger, higher educated, non-religious respondents with a background in the health sec-
tor. Respondents were more willing to provide ‘traditional’ types of health data, such as
health questionnaires, blood or biological samples, as opposed to social media or app-
related data. All respondents valued the return of individual research results, including risk
for diseases for which no treatment is available. Our findings highlight that alongside general
positive attitudes towards personalized health research using data and samples, respon-
dents have concerns about data privacy and re-use. Concerns included potential discrimina-
tion, confidentiality breaches, and misuse of data for commercial or marketing purposes.
The findings of this large-scale survey can inform Swiss research institutions and assist pol-
icymakers with adjusting practices and developing policies to better meet the needs and
preferences of the public. Efforts in this direction could focus on research initiatives engag-
ing in transparent communication, education, and engagement activities, to increase public
understanding and insight into data sharing activities, and ultimately strengthen personal-
ized health research efforts.
Introduction
Personalized health research has received increasing attention and support over recent years
in Switzerland. The European Commission defines personalized health as developing a
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“medical model using characterization of individuals’ phenotypes and genotypes (e.g. molecu-
lar profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the
right person at the right time and/or to determine the predisposition to disease and/or to
deliver timely and targeted prevention” [1]. As the latter description suggests, this research
depends on the willing contribution of large amounts of health data and genetic information
by individuals [2]. Yet, the extent to which the Swiss public today concurs or disagrees with
research biobanks using genetic and health data remains unknown. Established Swiss cohorts
are the Swiss HIV cohort, a systematic longitudinal study enrolling more than 20’000 HIV-
infected individuals in Switzerland, which was established in 1988 and SAPALDIA (Study on
Air Pollution And Lung Disease In Adults), which investigates the effects of life style and envi-
ronment on chronic diseases and aging in 10’000 adults of the Swiss general population since
1991. In terms of biobanks, 37 biobanks and biobank infrastructures are registered in the
Swiss Biobanking Platform. They are mainly affiliated to the five Swiss university hospitals. To
pool available data and to foster genetic research through a nationally coordinated data infra-
structure, the federal government established the Swiss Personalized Health Network (SPHN)
in 2017.
What little we do know about the Swiss public’s perceptions of personalized health to date
comes from a public survey mandated by the Swiss Federal Office of Public Health in 2018, as
well as studies involving patients receiving medical treatment [3, 4]. The former survey of
1,983 Swiss residents revealed that citizens had limited knowledge about research with humans
and its legalities in Switzerland. Interestingly, despite being generally uninformed, approxi-
mately half of respondents were hypothetically willing to provide their data in the form of
questionnaires or biological samples for human research purposes [4]. Similarly, a study
assessing the consent of 25,000 hospital patients revealed that 79% were willing to provide per-
sonal data and blood samples for research [4]. These studies help paint a picture of Swiss public
perspectives, yet do not depict a representative overview. To support governmental efforts and
promote personalized health research and its future developments in Switzerland, we need to
better understand what motivates and concerns potential contributors of data and biological
samples, and identify what they expect from personalized health research infrastructures. We
can then address these needs when building or expanding biobanks and establishing personal-
ized health research cohorts. To meet this need, we invited a representative sample of 15,106
Swiss residents to respond to our survey. Our goal was to identify motives, concerns, and
expectations of the Swiss public about providing health information and biological material
for personalized health research.
This paper presents findings from a survey about the Swiss public’s willingness, attitudes,
and concerns regarding participation in personalized health research. First, we report on the
demographic profiles of survey participants and their willingness to donate health information
and biological material for personalized health research. Second, we present participant opin-
ions towards research with human biological samples and preferences for providing certain
data types. Third, we outline concerns about participation in personalized health research and
which kinds of results participants prefer to receive.
Methods
Sample
We conducted a cross-sectional survey with a potential sample of 15,106 individuals in Swit-
zerland to explore attitudes, concerns, and expectations towards the hypothetical provision of
health and genetic data for personalized health research. The size of the sampling frame was
determined according to power analyses, assuming a response rate of 25%. Participants had to
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 2 / 17
Competing interests: The authors have declared
that no competing interests exist.
be over 18 years of age and reside in Switzerland. The Swiss Federal Statistical Office (FSO)
provided the stratified random sample which covered gender, four age groups (between 18
and 64+), and the three main language regions (German, French, Italian) across all geographi-
cal regions in Switzerland. The minority language regions (French, Italian) were oversampled.
Although 62% of the Swiss population speak German, 23% French, and 8% Italian [5], sam-
pling accounted for 2:1:1 for German, French and Italian so that a sufficient amount of
responses from the French and Italian speaking population could be reached. The legal basis
for the provision of samples is Article 13c (2) of the Swiss Statistical Survey Ordinance (SR
431.012.1).
Participants were notified of the survey by regular mail in their language of correspondence,
which they indicated upon registration at their municipality. They first received a letter briefly
describing the scope and background of the study, with instructions to complete the survey
online using a dedicated web platform available in German, French, Italian, and English
(Qualtrics). The letter also provided participants with a secure individualized login password,
which enabled anonymous tracking of individual responses. We then sent two reminders to
non-responders after three and seven weeks. The paper-based version of the questionnaire was
also attached in the second reminder (in the indicated language of correspondence), with a
pre-paid envelope for returning the questionnaire to the research team. The paper-based ques-
tionnaires also contained unique personal codes that matched participants’ answers with their
sociodemographic characteristics, as provided by the FSO. If a participant filled out both ver-
sions, we only included the online version.
By completing the questionnaire, participants provided their informed consent. We col-
lected answers for 20 weeks (16th September 2019 until 31st January 2020) until responses
abridged. The project complies with data protection regulations at each research institution
(ETH Zurich and the University of Bern). The Ethics Committee of ETH Zurich (EK 2018-N-
66) approved the study.
Questionnaire development and pretesting
Based on a narrative literature review of scholarly articles on donating health data for research,
we developed a conceptual framework (Fig 1) that delineates six underlying concepts of indi-
viduals’ willingness to donate health data and biological material for research purposes. Identi-
fied categories included general attitude, motivations and concerns, as well as expectations
towards data management, data governance, data sharing and uses, and willingness to receive
results. Although the survey explored all six categories, this paper focuses on three which cap-
ture the general expectations towards donating data and biological material for personalised
health research: attitudes, concerns, and willingness to receive results.
Based on the conceptual framework, we drafted and refined an English language question-
naire. The outcome consisted of 23 closed (binary and 5-point Likert scale) and multiple-
choice items (see supplementary material). For some questions, the answer options “I don’t
know” and/or “other” were provided. In the online survey, questions could not be skipped.
We then translated the questionnaire from English into the three main languages in Switzer-
land: German, French, and Italian. Each translation was revised and checked by two native
speakers to ensure the highest level of concept-matching and language accuracy. To ensure
readability, construct, and content validity, we conducted a two-wave pilot test: first an expert
wave and second a convenience sample wave. The first wave involved 14 experts in the field of
bioethics and health sciences. Nine provided written feedback, and five filled out the question-
naire and commented in a cognitive interview. Results of this expert wave helped refine and
improve the clarity, stringency, and exhaustiveness of the survey questions. The research team
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then conducted pretesting with the convenience sample to evaluate readability and compre-
hension among the target population. The expert sample from the first wave identified the par-
ticipants for this step by applying snowball sampling in their social networks. As a result, the
individuals selected represented different age and gender groups, and divergent geographical,
language, educational, and socioeconomic backgrounds. Data collection for the pilot test con-
tinued until data saturation was achieved at 17 responses. Based on the latter results, we then
revised and updated the survey translations.
Fig 1. Individual’s willingness to participate in personalized health research—A conceptual framework.
https://doi.org/10.1371/journal.pone.0249141.g001
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Statistical analysis
We analysed the data using the software STATA (version 15, College Station, TX, USA). Before
analysis, we evaluated data for completeness and normal distribution of continuous variables.
We included only questionnaires with a minimum of 50% data completeness. The research
team matched the survey data with participants’ demographics through a unique identifier.
The demographic data linked from FSO data included gender, age, language, household size,
nationality, marital status, and municipality of residence. In a next step, we calculated and
applied survey weights (using gender, age, language region) to account for differences between
respondents and the general population of Switzerland. For obtaining relative proportions, we
used modified multivariable Poisson regression to adjust for confounders and identify factors
independently associated with willingness to provide health data and biological samples for
personalized health research [6]. We used relative proportions because they enable a more
straightforward interpretation compared to odds ratios for instance. For example, comparing
a proportion of 60% to one of 30% results in a relative proportion of 2.0, but an odds ratio of
3.5. In addition to the variables provided by the FSO, we included the type of response (online
vs. paper-based) and the self-reported variables of biological children, education, religious
views, working in the health sector, and health status in the analyses. Thus our analysis
included the variables: age, gender, nationality, number of household members, marital status,
having biological children, language region, residence in a urban/rural municipality, educa-
tion, religiousity, currently or previously working in the health sector, health status, and the
type of survey response.
Results
Sample description
We received a total of 5,156 responses, representing an overall response rate of 34.1%. We
received 950 responses after the initial invite, 2,834 after the first reminder and 1,372 after the
second reminder. The majority, 3,519 (68%), were web-based responses. We deleted 70
responses: 63 which were paper-based with less than 50% answers completed, four duplicates
completed as both online and paper-based, and three paper-based questionnaires with missing
identifiers. The final analysis thus contained 5,086 complete responses (a 33.7% response rate
after excluding incomplete questionnaires). S1 Table portrays the key demographic character-
istics of respondents and non-respondents. The percentage of the following characteristics dif-
fered between the responder and non-responder group: Swiss nationality (respondents: 82.9%
vs. non-respondents: 71.8% vs. total sample: 75.6%), Non-Swiss nationality (17.1% vs. 28.2%
vs. 24.4%), one household member (15% vs. 19.5% vs. 17.9%), single persons (32.6% vs. 40.7%
vs. 37.9%) as well as married persons (53.9% vs. 45.6% vs. 48.4%). Table 1 presents an overview
of the distribution of respondents by sociodemographic characteristics, the proportion of
respondents willing to participate in a health research project, and results of the adjusted
model using modified Poisson regression (all weighted proportions except n).
Willingness to provide health data and biological samples
More than half of respondents (53.6%) indicated a willingness to participate in a hypothetical
personalized health research study by providing health data and/or biological samples. The
analysis showed willingness varied with sociodemographic characteristics (Table 1). The big-
gest differences were found in age (18–24 years: 60.7%, 75–79 years: 44.4%), education (com-
pulsory education or less: 30.3%, tertiary education: 65.5%), self-reported religiosity (very
much: 45.6%, not at all: 59.4%), number of household members (1 person: 56.2%, 6 persons
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Table 1. Willingness to participate in personalized health research by providing health data and biological samples according to sociodemographic factors
(weighted proportions).
Sample Population Proportion willing to participate
& provide health data & samples
Adjusted Relative Proportion (RP)
n % 95% CI % 95% CI adjusted RP 95% CI
Total 5,086 100 53.57 [51.86,55.26]
Age group p = 0.0167
18–24 594 8.63 [7.84,9.49] 60.74 [55.87,65.42] 1.29 [1.12,1.49]
25–34 758 17.65 [16.32,19.07] 59.93 [55.59,64.12] 1.16 [1.03,1.31]
35–44 632 18.51 [17.05,20.07] 56.51 [51.83,61.08] 1.12 [1.00,1.26]
45–54 927 19.48 [18.18,20.86] 48.88 [45.06,52.72] 1
55–64 1,005 17.46 [16.28,18.71] 51.94 [48.14,55.71] 1.04 [0.93,1.16]
65–74 857 13.1 [12.14,14.12] 48.63 [44.70,52.58] 0.98 [0.87,1.11]
75–79 313 5.16 [4.53,5.87] 44.41 [37.92,51.09] 0.91 [0.77,1.09]
Total 5,086 100 53.57 [51.86,55.26]
Sex p = 0.8628
Male 2,451 50.09 [48.39,51.79] 53.47 [50.99,55.94] 1
Female 2,635 49.91 [48.21,51.61] 53.66 [51.32,55.99] 1.01 [0.94,1.07]
Total 5,086 100 53.57 [51.86,55.26]
Nationality p = 0.0404
Swiss 4,216 76.03 [74.35,77.62] 54.69 [52.87,56.51] 1
Non-Swiss 870 23.97 [22.38,25.65] 49.99 [45.88,54.10] 0.91 [0.83,1.00]
Total 5,086 100 53.57 [51.86,55.26]
Number of household members p = 0.0355
1 760 18.12 [16.73,19.58] 56.16 [51.70,60.53] 1
2 1,854 35.47 [33.89,37.09] 54.06 [51.30,56.80] 1 [0.91,1.11]
3–5 2,347 43.65 [41.99,45.34] 52.82 [50.30,55.33] 0.91 [0.81,1.02]
6 persons and more 125 2.75 [2.24,3.39] 42.13 [32.20,52.73] 0.76 [0.59,0.99]
Total 5,086 100 53.57 [51.86,55.26]
Marital status p = 0.3284
single 1,669 35.25 [33.59,36.94] 59.46 [56.43,62.42] 1
married 2,733 50.93 [49.23,52.64] 49.38 [47.09,51.67] 0.96 [0.86,1.07]
widowed 150 3.1 [2.58,3.73] 50.72 [41.35,60.05] 1.09 [0.87,1.36]
divorced 534 10.72 [9.73,11.80] 54.8 [49.66,59.83] 1.05 [0.92,1.20]
Total 5,086 100 53.57 [51.86,55.26]
Biological children p = 0.2843
Yes 2,968 57.62 [55.91,59.32] 50.82 [48.63,53.00] 1
No 2,074 42.38 [40.68,44.09] 57.62 [54.91,60.30] 0.95 [0.87,1.04]
Missing 44
Total 5,086 100 53.7 [51.99,55.40]
Language region p = 0.0168
German 2,257 70.76 [70.30,71.23] 54.33 [52.14,56.51] 1
French 1,366 24.51 [24.06,24.97] 51.02 [48.16,53.88] 0.93 [0.87,1.00]
Italian 1,463 4.72 [4.63,4.81] 55.25 [52.54,57.92] 1.03 [0.97,1.10]
Total 5,086 100 53.57 [51.86,55.26]
Urban/rural municipality p = 0.2382
urban 3,104 61.04 [59.39,62.67] 54.07 [51.86,56.27] 1
intermediary 1,086 21.64 [20.30,23.05] 54.51 [50.93,58.05] 1.07 [0.99,1.15]
rural 896 17.31 [16.09,18.60] 50.57 [46.59,54.55] 1.01 [0.92,1.10]
Total 5,086 100 53.57 [51.86,55.26]
(Continued)
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 6 / 17
and more: 42.1%), working in the health sector (yes: 62.2%, no: 51.4%), marital status (single:
59.5%, married: 49.4%), having biological children (yes: 50.8%, no: 57.6%), health status (very
unhealthy: 49.7%, very healthy: 55.2%) and nationality (Swiss: 54.7%, Non-Swiss: 50%).
Based on the multivariable analysis (Table 1), we found the younger age groups more will-
ing to participate (18–24: adjusted Relative Proportions (aRP) = 1.29, 95% CI: 1.12–1.49; 25–
34: aRP = 1.16, 95% CI: 1.03–1.31) compared to older age groups (55–64; 65–74; 75–79). Per-
sons without Swiss nationality, from the French language region, and living in large house-
holds (6 persons and more) were found to be less willing to provide health data and biological
samples. We found level of education to have the strongest association with willingness to par-
ticipate. Compared to respondents with upper secondary education, those with compulsory
education or less were less willing (aRP = 0.66, 95% CI: 0.55–0.80) whereas people with tertiary
education were more willing (aRP = 1.24, 95% CI: 1.16–1.33) to participate. Furthermore, we
found the relative proportion of willingness to participate in a health research project higher
for non-religious persons or those who currently or previously worked in the health sector.
Table 1. (Continued)
Sample Population Proportion willing to participate
& provide health data & samples
Adjusted Relative Proportion (RP)
n % 95% CI % 95% CI adjusted RP 95% CI
Education p = 0.0000
Compulsory education or less 385 8.36 [7.44,9.37] 30.32 [24.96,36.27] 0.66 [0.55,0.80]
Upper secondary education 3,394 65.23 [63.57,66.86] 51.73 [49.65,53.80] 1
Tertiary education 1,283 26.41 [24.90,27.98] 65.52 [62.19,68.71] 1.24 [1.16,1.33]
Missing 24
Total 5,086 100 53.61 [51.90,55.31]
Religion p = 0.0023
Very much 695 13 [11.92,14.17] 45.58 [41.00,50.24] 1
Somewhat 2,217 43.55 [41.87,45.25] 50.43 [47.84,53.01] 1.06 [0.94,1.18]
Not at all 2,138 43.45 [41.76,45.15] 59.37 [56.78,61.91] 1.17 [1.04,1.30]
Missing 36
Total 5,086 100 53.69 [51.98,55.39]
Working in health sector? p = 0.0001
Yes 1,010 20.17 [18.83,21.57] 62.15 [58.37,65.78] 1
No 4,063 79.83 [78.43,81.17] 51.39 [49.47,53.29] 0.86 [0.80,0.93]
Missing 13
Total 5,086 100 53.55 [51.85,55.25]
Health status p = 0.5630
Very unhealthy 61 0.76 [0.53,1.10] 49.65 [32.40,66.99] 1
Somewhat unhealthy 115 2.02 [1.62,2.52] 47.4 [36.44,58.61] 1.05 [0.68,1.61]
Neutral 661 13.51 [12.38,14.73] 52.05 [47.36,56.70] 1.04 [0.72,1.51]
Somewhat healthy 2,578 47.13 [45.45,48.82] 53.39 [50.95,55.81] 1 [0.70,1.44]
Very healthy 1,643 36.57 [34.93,38.24] 55.18 [52.28,58.05] 0.96 [0.67,1.38]
Missing 28
Total 5,086 100 53.72 [52.01,55.42]
Type of response p = 0.0000
Web-based 3,519 71.04 [69.50,72.54] 57.03 [55.00,59.03] 1
Paper-based 1,567 28.96 [27.46,30.50] 44.87 [41.79,48.00] 0.83 [0.77,0.90]
Total 5,086 100 53.57 [51.86,55.26]
https://doi.org/10.1371/journal.pone.0249141.t001
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Regarding type of response, 57.0% of the web-based responses indicated a willingness to
participate, compared with 44.9% willingness by paper-based respondents. The sociodemo-
graphic characteristics between these sub-samples show that respondents using the paper-
based questionnaire were often older, female, living in smaller households, not single, had bio-
logical children, and had lower levels of education (see S2 Table). However, analysis of the
responses as a whole revealed that except for having biological children, the factors of gender,
marital status, health status, or residence in an urban/rural municipality did not impact
respondents’ willingness to participate. In addition, after adjusting for multiple characteristics
in the Poisson regression analysis, the association between lower willingness to participate and
persons who responded via paper-based questionnaire persisted (aRP = 0.83, 95% CI: 0.77–
0.90).
Awareness and opinion towards research with human biological samples
The majority of respondents (71%) reported awareness of research using human biological
samples. As shown by Fig 2, a majority indicated a rather positive attitude towards such
research, with responses of “somewhat positive” (44.27%, n = 2,424) or “very positive”
(18.09%, n = 1,021). Only 4.67% indicated having a “somewhat negative” opinion (n = 209)
and 1.42% a “very negative” opinion (n = 53). The analysis revealed that willingness to partici-
pate in personalized health research was 11 times more likely in respondents reporting an
opinion of “very positive” compared to “very negative” [aRP = 11.22, 95% CI: 4.17–30.21].
Sensitivity towards different types of data
Fig 3 shows the types of data respondents indicated being willing to share. A majority of those
who are willing to share their health data and/or biological samples indicated they would like
to share questionnaires about their health status (85.59%, n = 2,352), blood samples (84.56%,
n = 2,326 respondents), and self-collected biological samples, such as hair, saliva, or urine
Fig 2. Opinion towards research with human biological samples.
https://doi.org/10.1371/journal.pone.0249141.g002
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(81.62%, n = 2,224 respondents). Only a few respondents were willing to share data derived
from apps about their health or lifestyle (such as heart rates, exercise trackers, or food logs;
34.29%, n = 994) or their social media data (14.53%, n = 392).
Concerns about participation
Respondents expressed several concerns about participating in a research project that would
use their health data and/or biological samples. As shown in Fig 4, participants could choose
up to three concerns most relevant to them. Out of all respondents (5,025 persons, 13,371
answers in total), most were worried that participation could lead to discrimination against
them or their family (46.8%). This concern was closely followed by the concern that their data
would not be kept confidential (46.3%) or would be misused for commercial or marketing pur-
poses (45.5%). Additional frequent concerns were that someone might hack and steal their
data (31.9%) and that others would benefit financially from their data (31.2%). These five most
frequent concerns were consistent whether or not respondents were willing to participate in a
personalized health research project. However in 10 of the 14 response options we discovered
differences between these two groups (Fig 4). Individuals not willing to participate were less
concerned that the data would be used to discriminate against them and their family (willing:
53.2%, not willing: 43.8%) or would be misused for commercial or marketing purposes (will-
ing: 48.9%, not willing: 37.6%), but were more concerned about research involving genetic
information (willing: 8.1%, not willing: 25.9%).
The willingness to receive results
Table 2 reports the types of research results that participants would hypothetically like to
receive if participating in a personalized health research study. Respondents were generally
Fig 3. Willingness of respondents to provide specific types of data.
https://doi.org/10.1371/journal.pone.0249141.g003
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interested in receiving results, however preferences differed slightly. A large majority reported
wanting to receive details about their basic medical information, e.g. blood count (83.2% indi-
cated “yes, 10.0% “no”, and 6.8% “don’t know”). Many participants also indicated a wish to
receive information about the following; risk for diseases with available medical treatment (e.g.
some types of cancer) (73.8%); risk for diseases for which only preventive action can be under-
taken (e.g. heart disease) (72.6%); and effects of lifestyle (e.g. smoking, weight etc.) on one’s
risk of a medical condition (69.6%).
Fewer respondents wished to receive general research results about the study, which do not
apply to them individually (66.2%). Fewest respondents chose to receive results about risk of
diseases for which no medical treatment is available, but that could impact their well-being or
decisions about their career or family planning (e.g. Alzheimer’s disease or dementia) (54.4%).
Respondents who indicated their willingness to participate in a personalized health research
project are also more interested in receiving individual research results than those who are not
Fig 4. Overview of concerns for persons willing and not willing to participate in a personalized health research project by providing health data
and biological samples. �Indicates statistical difference between these two groups, p<0.05.
https://doi.org/10.1371/journal.pone.0249141.g004
Table 2. Willingness to receive distinct types of research results (weighted proportions).
Overall Willing to participate Not willing to participate
Type of research results Yes No Don’t know Yes No Don’t know Yes No Don’t know
Basic medical information 83.2 10.0 6.8 90.8 6.4 2.8 74.3 14.2 11.4
Lifestyle affects my risk of getting a medical condition 69.6 22.3 8.2 79.6 16 4.4 58 29.6 12.4
Diseases for which medical treatments are available 73.8 16.1 10.2 83.7 10.2 6.1 62.1 23.1 14.9
Diseases for which only preventive actions can be undertaken 72.6 17.5 10.0 81.9 12.4 5.7 61.7 23.4 14.9
Diseases for which no treatment is available 54.4 30.5 15.1 64 25.1 10.9 43.2 37 19.8
Research results about the study in general 66.2 19.7 14.1 77.9 13.8 8.3 52.8 26.6 20.6
https://doi.org/10.1371/journal.pone.0249141.t002
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willing to participate. Those who are not willing to participate furthermore chose more often
the answer option “don’t know”.
Discussion
Results show that just over half of respondents (53.6%) in this diverse national sample would
be willing to participate in a personalized health research project by providing health data and/
or biological samples. This finding aligns with results from a 2018 Swiss study, which reported
a willingness of 49% [3]. Upon comparison, similar surveys from other countries demonstrate
higher rates: with 86% in Italy [7], 86% in Sweden [8], 83.5% in Korea [9], 70.4% in Germany
[10]. Others show similar rates: with 56% in Germany [11], and 54% in the US [12]. At the
same time, a global survey of 36,268 respondents across 22 countries indicated that willingness
to donate data to doctors, and non-profit and for-profit researchers, was generally “low”
(47.4%), with variation among countries (from 29% in Japan up to 63.7% in Mexico) [13].
These differences in outcomes imply that results of comparable international studies must be
carefully interpreted. Several factors might explain the divergence: whether or not studies
occurred in a healthcare setting or not, phrasing of survey questions, and the population sur-
veyed (general population, patients, or research participants), as well as interpretation of out-
comes as low or high. For example, the Italian survey sample consisted of family members of
geriatric outpatient unit patients [7], who might be potentially more open-minded towards
health care and health research. Generalizing or comparing findings across contexts is there-
fore not always possible. One potential reason why our survey results indicate lower rates of
willingness in Switzerland could be the high value placed on autonomy and individual respon-
sibility among the Swiss population [14]. Preserving one’s health would take priority over
donating data or samples to health research. In addition, Swiss law treats personal health data
and biological samples as sensitive, reinforcing the common understanding that such data
must be protected [15].
Our finding that willingness to participate in personalized health research is significantly
higher among young (18–24 years), highly educated, and non-religious participants, particu-
larly those with a background in health care, corresponds with similar biobank and research
participation studies [12, 16–18]. To compare different points in time, we did not find many
similar studies. Yet two studies from 2001 from the US [19] and 2004 from Singapore [20],
show that 42% and 49.3% of respondents were willing to donate and store blood for genetic
research, indicating no significant differences in the last 20 years. Although age, education,
religion, and background in healthcare have been clearly shown to influence willingness to
participate in research, actions undertaken in recent years to improve participation, also
among unrepresented groups, remain less well reported. Nevertheless, some guidance does
exist. For example, running information campaigns designed for different ages and educa-
tional levels prior to a research endeavor have been shown to increase enrolment across diverse
groups [21]. However, actual participation rates in human and biobank research consistently
remain lower than self-reported, hypothetical willingness [22]. This difference could result
from logistical and time constraints, or lack of practical information about where and how to
participate. Taking these points into consideration and fostering public engagement will be
key for achieving higher willingness and participation levels in Switzerland.
In deciding whether or not to participate in a personalized health research study, individu-
als weigh possible benefits against potential risks [3], balancing concern for privacy loss against
openness to giving data [23]. Although previous studies confirm privacy-related concerns [18,
24], they do not explore which concerns are most significant [25]. Our study differs in that it
identifies three primary participation concerns for the Swiss public. These are concerns for
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potential discrimination, breaches of confidentiality, and misuse of data for commercial or
marketing purposes. As culture and context influence the public‘s understanding, it’s meaning
to them and their preferences surrounding privacy, research institutions should engage in tai-
lored education and public discussion, to increase understanding of this complex, often sub-
jective and emotive issue.
Given this background, it is not surprising that participants were least willing to donate
social media and app-related data. One possible explanation is that participants do not per-
ceive these data types as valuable to research as they do not stem from the bouquet of “tradi-
tional” health data. Another potential reason is a lack of trust in research using these data
types, fueled by recent scandals such as the Cambridge Analytica case where social media data
was used for undisclosed secondary purposes [26], or the so-called Emotional Contagion
Experiment, in which Facebook manipulated the news feed of nearly 700,000 users without
their knowledge, to test its ability to alter emotions [27]. International attention from these
scandals may have resulted in greater caution over sharing this type of data, and distrust of
tech giants with regard to health-related matters [28]. Given that survey participants explicitly
reported concerns about privacy and data misuse as most salient to them (as opposed to logis-
tical barriers, fears about physical or emotional harm, or lack of incentives), it is evident that
research institutions have novel challenges to solve.
One approach to rebuilding public confidence in research using non-traditional data is to
strengthen regulations that differentiate between voluntarily given or involuntarily observed
data–for the current regulatory situation resembles the “Wild West” [29]. At the same time,
transparency and public education communicating the benefits and limitations of the use of
different data types can be strengthened. For example, research institutions should communi-
cate to data donors which types of data are used, under which conditions they may be shared,
and the measures in place to guarantee confidentiality and prevention of data misuse [30].
Communication of current agreements and codes of conduct in the health data ecosystem
could also be a way forward. This could promote citizen engagement with data governance
while fostering transparency and trust in the use of health data [29].
In terms of return of results to the research participant, our findings demonstrate that the
majority of respondents would like to receive various types of general and individual results.
In research practice, the return of individual research results to participants has long been
avoided. Reasons for this abound and include: that research aims to advance knowledge
instead of treating individuals; risks can arise in disclosing non-validated genetic findings; and
the return has costs associated. Additionally, the therapeutic misconception describes research
subjects’ belief to benefit from some form of medical care through participation in a study
[31]. In recent years, however, scientific societies and scholars have argued that researchers
have broader responsibilities towards their participants, including a duty to inform partici-
pants about results produced in the course of research. In line with this, respondents of our
study expressed a wish to receive results about risk of diseases for which no medical treatment
is available, but that could impact well-being or decisions about career or family planning (e.g.
Alzheimer’s disease). This finding is consistent with other studies, which found that some
research participants wish to obtain results which are not clinically actionable [17, 32].
To accommodate participants’ differing preferences and to strengthen trust in research, ini-
tiatives such as the American All of Us Research Program among others plan to provide the
option to choose which type of results are returned [33]. In Switzerland, the Swiss Personalized
Health Network (SPHN) recently published recommendations for ethical and responsible
reporting of genetic research findings to participants. These recommendations promote
reporting of any findings with medical significance, whether within the scope of the study or
secondary findings and hence align with this study’s results [34].
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Since we conducted this survey between September 2019 and January 2020, our findings
present a unique baseline dataset of Swiss public opinions regarding data provision for person-
alized health research. The global climate around health data and research has since changed
due to the COVID-19 pandemic, with Switzerland’s first case reported in February 2020. In
efforts to better understand how this novel virus acts on a molecular and population level, and
to tailor public health measures, countries and researchers worldwide are increasingly using
data. At the same time, the debate around the use of data has grown. On one hand, many fear
the deployment of surveillance through data-driven efforts [35, 36]. On the other hand, others
argue that public perception of data will change and open the opportunity for new social con-
tracts, as everyone experiences first-hand the need and value of health data for research [37].
Indeed, it will be interesting to identify whether the COVID-19 pandemic changes the Swiss
public’s attitude towards sharing health data or towards privacy-related concerns in any way.
We thus recommend a follow-up survey on whether the COVID-19 pandemic changed Swiss
citizen’s willingness to provide data for health research, to understand consequences for the
future.
A methodological limitation of our study–which is inherent to most surveys–is the self-
selection bias of respondents, who agree to answer the survey and are willing to provide their
data. Individuals who are more positive towards personalized health research could thus be
reflected in our sample. Willingness rates might be lower in reality than our results suggest.
Furthermore, this survey captures respondents’ attitudes and opinions at a single point in
time. A longitudinal survey study could more thoroughly assess how respondents’ views
develop and change. As a future direction for research, qualitative studies on what influences
citizens’ willingness to provide data and/or samples for personalized health research could
yield deeper insights beyond those possible in a survey design. Nonetheless, a strength of our
study is a diverse sample representing Swiss residents of all sociodemographic characteristics,
regions, and languages spoken. Compared to similar studies, the response rate of our survey is
acceptable to fairly high (e.g. 2.9% in Korea [9], 20.4% in Germany [10], and 54% in the US,
which however surveyed a panel of persons who have registered at an online survey firm [12]).
By weighting the results, we accounted for the variation in response rates across age, gender
and language groups. However, we cannot exclude that respondents’ attitudes (within these
subpopulations) differ from those who did not respond. Nevertheless, the correction for any
effects of age, gender, and language will have attenuated non-response bias. We believe that
the weighted analysis results reflect the attitudes and willingness to participate in personalized
health research studies of the Swiss population. Therefore, we deem the results to be broadly
generalizable to the Swiss population. As respondents had the choice between the web-based
or paper-based questionnaire, our survey also represents those less digitally literate or willing
to use digital tools.
Conclusion
Knowing what drives decisions to join personalized health research projects and biobanks is
crucial to establishing and maintaining such endeavours successfully. This study presents
insights into the Swiss public’s willingness to participate in personalized health research by
providing data and/or biological samples. It highlights that personalized health research is sup-
ported by slightly more than half of the Swiss public, but that concerns about discrimination,
confidentiality and misuse of data for commercial or marketing purposes exist and need to be
addressed. The findings can inform Swiss research institutions and policymakers, to adjust
practices and develop policies to better meet the needs and preferences of the public. We con-
clude that besides the implementation transparent communication on the part of research
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initiatives, tailored public discussions, education, and engagement activities for potential par-
ticipants are needed, to increase insights into data sharing activities and enable informed
choices.
Supporting information
S1 Table. Respondents and non-respondents.
(DOCX)
S2 Table. Socio-demographic characteristics displayed for chosen type of response. Not
weighted.
(DOCX)
S1 File. Frequency tables.
(DOCX)
S2 File. Questionnaire English.
(PDF)
S3 File. Questionnaire German.
(PDF)
S4 File. Questionnaire French.
(PDF)
S5 File. Questionnaire Italian.
(PDF)
S6 File. Invitation letter German.
(PDF)
S7 File. Invitation letter French.
(PDF)
S8 File. Invitation letter Italian.
(PDF)
S9 File. First reminder German.
(PDF)
S10 File. First reminder French.
(PDF)
S11 File. First reminder Italian.
(PDF)
S12 File. Second reminder German.
(PDF)
S13 File. Second reminder French.
(PDF)
S14 File. Second reminder Italian.
(PDF)
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 14 / 17
Acknowledgments
We thank members at the Health Ethics & Policy Lab at ETH Zurich for discussions on the
questionnaire development and pre-testing, Christoph Freymond from the Federal Office for
Statistics for providing the data sample, Stefan Wehrli and his team from the Decision Sciences
Laboratory at ETH Zurich for setting up and maintaining the Call Center and data collection
infrastructure, Jan Kaiser for automating the digitalisation of the paper-based questionnaires
and Stephanie Bishop, Joanna Sleigh and Shannon Hubbs for editing this manuscript.
Author Contributions
Conceptualization: Claudia Berlin, Marcel Zwahlen, Matthias Egger, Effy Vayena.
Data curation: Caroline Brall, Claudia Berlin.
Formal analysis: Caroline Brall, Claudia Berlin, Marcel Zwahlen, Matthias Egger, Effy
Vayena.
Funding acquisition: Effy Vayena.
Methodology: Caroline Brall, Claudia Berlin, Marcel Zwahlen, Kelly E. Ormond, Matthias
Egger, Effy Vayena.
Project administration: Caroline Brall.
Supervision: Marcel Zwahlen, Kelly E. Ormond, Matthias Egger, Effy Vayena.
Visualization: Caroline Brall, Claudia Berlin.
Writing – original draft: Caroline Brall.
Writing – review & editing: Caroline Brall, Claudia Berlin, Marcel Zwahlen, Kelly E. Ormond,
Matthias Egger, Effy Vayena.
References
1. European Commission. Council conclusions on personalised medicine for patients. Off J Eur Union.
2015; C421(03):2–6.
2. Flores M, Glusman G, Brogaard K, Price ND, Hood L. P4 medicine: How systems medicine will trans-
form the healthcare sector and society. Per Med. 2013; 10(6):565–576. https://doi.org/10.2217/pme.13.
57 PMID: 25342952
3. Ehrler F, Lebert F. Wissensstand und Haltung der Allgemeinbevölkerung zur Humanforschung und
deren Regelungen. [Level of knowledge and attitude of the general population to human research and
its regulations]. 2018 [Cited 2020 Nov 04]. https://www.bag.admin.ch/bag/de/home/das-bag/
ressortforschung-evaluation/forschung-im-bag/forschung-biomedizin/ressortforschungsprojekte-
humanforschung.html#811948822
4. Bochud M, Currat C, Chapatte L, Roth C, Mooser V. High participation rate among 25 721 patients with
broad age range in a hospital-based research project involving whole-genome sequencing—the Lau-
sanne Institutional Biobank. Swiss Med Wkly. 2017; 147(4142):w14528.
5. Federal Statistical Office. Languages. [Cited 2021 Feb 25]. https://www.bfs.admin.ch/bfs/en/home/
statistics/population/languages-religions/languages.html
6. Zou G. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epide-
miol. 2004; 159(7):702–6. https://doi.org/10.1093/aje/kwh090 PMID: 15033648
7. Porteri C, Pasqualetti P, Togni E, Parker M. Public’s attitudes on participation in a biobank for research:
An Italian survey. BMC Med Ethics. 2014; 15(1):1–10.
8. Kettis-Lindblad Å, Ring L, Viberth E, Hansson MG. Genetic research and donation of tissue samples to
biobanks. What do potential sample donors in the Swedish general public think? Eur J Public Health.
2006; 16(4):433–40. https://doi.org/10.1093/eurpub/cki198 PMID: 16207726
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 15 / 17
9. Kim H, Kim HR, Kim S, Kim E, Kim SY, Park HY. Public Attitudes Toward Precision Medicine: A Nation-
wide Survey on Developing a National Cohort Program for Citizen Participation in the Republic of
Korea. Front Genet. 2020; 11(May):1–9. https://doi.org/10.3389/fgene.2020.00283 PMID: 32477396
10. Bossert S, Kahrass H, Strech D. The public’s awareness of and attitude toward research biobanks—A
regional German survey. Front Genet. 2018; 9:1–11.
11. Voigt TH, Holtz V, Niemiec E, Howard HC, Middleton A, Prainsack B. Willingness to donate genomic
and other medical data: results from Germany. Eur J Hum Genet. 2020; 28(8):1000–9. PMID:
32238912
12. Kaufman DJ, Baker R, Milner LC, Devaney S, Hudson KL. A survey of U.S adults’ opinions about con-
duct of a nationwide Precision Medicine Initiative® cohort study of genes and environment. PLoS One.
2016; 11(8):1–14. https://doi.org/10.1371/journal.pone.0160461 PMID: 27532667
13. Middleton A, Milne R, Almarri MA, Anwer S, Atutornu J, Baranova EE, et al. Global Public Perceptions
of Genomic Data Sharing: What Shapes the Willingness to Donate DNA and Health Data? Am J Hum
Genet. 2020 Sep; 107:1–10. https://doi.org/10.1016/j.ajhg.2020.08.023 PMID: 32946764
14. Biller-Andorno N, Zeltner T. Individual Responsibility and Community Solidarity—The Swiss Health
Care System. N Engl J Med. 2015 Dec 3; 373(23):2193–7. https://doi.org/10.1056/NEJMp1508256
PMID: 26630139
15. Martani A, Egli P, Widmer M, Elger B. Data protection and biomedical research in Switzerland: setting
the record straight. Swiss Med Wkly. 2020 Sep 1; 150:w20332. https://doi.org/10.4414/smw.2020.
20332 PMID: 32920795
16. Shabani M, Bezuidenhout L, Borry P. Attitudes of research participants and the general public towards
genomic data sharing: A systematic literature review. Expert Rev Mol Diagn. 2014; 14(8):1053–65.
https://doi.org/10.1586/14737159.2014.961917 PMID: 25260013
17. Goodman D, Bowen D, Wenzel L, Tehrani P, Fernando F, Khacheryan A, et al. The Research partici-
pant perspective related to the conduct of genomic cohort studies: A systematic review of the quantita-
tive literature. Transl Behav Med. 2018; 8(1):119–29. https://doi.org/10.1093/tbm/ibx056 PMID:
29385589
18. Sanderson SC, Brothers KB, Mercaldo ND, Clayton EW, Antommaria AHM, Aufox SA, et al. Public Atti-
tudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey
in the US. Am J Hum Genet. 2017; 100(3):414–27. https://doi.org/10.1016/j.ajhg.2017.01.021 PMID:
28190457
19. Wang SS, Fridinger F, Sheedy KM, Khoury MJ. Public attitudes regarding the donation and storage of
blood specimens for genetic research. Community Genet. 2001; 4: 18–26. https://doi.org/10.1159/
000051152 PMID: 11493749
20. Wong ML, Chia KS, Yam WM, Teodoro GR, Lau KW. Willingness to donate blood samples for genetic
research: A survey from a community in Singapore. Clin Genet. 2004; 65: 45–51. https://doi.org/10.
1111/j.2004.00192.x PMID: 15032974
21. McMurdo MET, Roberts H, Parker S, Wyatt N, May H, Goodman C, et al. Improving recruitment of older
people to research through good practice. Age Ageing. 2011; 40(6):659–65. https://doi.org/10.1093/
ageing/afr115 PMID: 21911335
22. Johnsson L, Helgesson G, Rafnar T, Halldorsdottir I, Chia KS, Eriksson S, et al. Hypothetical and fac-
tual willingness to participate in biobank research. Eur J Hum Genet. 2010; 18(11):1261–4. PMID:
20648060
23. Vayena E, Gasser U. Between Openness and Privacy in Genomics. PLOS Med. 2016 Jan 12; 13(1):
e1001937. https://doi.org/10.1371/journal.pmed.1001937 PMID: 26757154
24. Middleton A, Milne R, Howard H, Niemiec E, Robarts L, Critchley C, et al. Members of the public in the
USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate
genomic data. Eur J Hum Genet. 2020; 28(4):424–34. PMID: 31784701
25. Clayton EW, Halverson CM, Sathe NA, Malin BA. A systematic literature review of individuals’ perspec-
tives on privacy and genetic information in the United States. PLoS One. 2018; 13(10):1–26. https://doi.
org/10.1371/journal.pone.0204417 PMID: 30379944
26. Ostherr K, Borodina S, Bracken RC, Lotterman C, Storer E, Williams B. Trust and privacy in the context
of user-generated health data. Big Data Soc. 2017 Jun 17; 4(1):205395171770467.
27. Kramer ADI, Guillory JE, Hancock JT. Experimental evidence of massivescale emotional contagion
through social networks. Proc Natl Acad Sci. 2014 Jul 22; 111(24):8788–90. https://doi.org/10.1073/
pnas.1320040111 PMID: 24889601
28. Watcher RM, Cassel CK. Risk, Benefit, and Fairness in a Big Data World. JAMA. 2019 Jul 9; 322
(2):105. https://doi.org/10.1001/jama.2019.9523 PMID: 31287512
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 16 / 17
29. Nebeker C, Torous J, Bartlett Ellis RJ. Building the case for actionable ethics in digital health research
supported by artificial intelligence. BMC Med. 2019; 17(1):1–7.
30. Gille F, Vayena E, Blasimme A. Future-proofing biobanks’ governance. Eur J Hum Genet. 2020 Aug 18;
28(8):989–96.
31. Bredenoord AL, Kroes HY, Cuppen E, Parker M, van Delden JJM. Disclosure of individual genetic data
to research participants: The debate reconsidered. Trends Genet. 2011; 27(2):41–7. https://doi.org/10.
1016/j.tig.2010.11.004 PMID: 21190750
32. Wilkins CH, Mapes BM, Jerome RN, Villalta-Gil V, Pulley JM, Harris PA. Understanding what informa-
tion is valued by research participants, and why. Health Aff. 2019; 38(3):399–407.
33. National Institutes of Health. All of Us Research Program. Operational Protocol. 2018 Mar 28 [Cited
2020 Nov 04]. https://allofus.nih.gov/about/all-us-research-program-protocol
34. SPHN. Recommendation: Reporting actionable genetic findings to research participants. 2020 [cited
2020 Nov 04]. https://sphn.ch/2020/05/19/reporting-actionable-genetic-findings-to-research-
participants/
35. Ram N, Gray D. Mass surveillance in the age of COVID-19. J Law Biosci. 2020; 7(1):1–17. https://doi.
org/10.1093/jlb/lsaa023 PMID: 32728466
36. Frith J, Saker M. It Is All About Location: Smartphones and Tracking the Spread of COVID-19. Soc
Media Soc. 2020; 6(3):2–5.
37. Mulgan G. How covid-19 could bring about new social contracts around data. The Economist—Per-
spectives. 2020 Apr 23 [Cited 2020 Nov 04]. https://eiuperspectives.economist.com/technology-
innovation/how-covid-19-could-bring-about-new-social-contracts-around-data
PLOS ONE Willingness to participate in personalized health research
PLOS ONE | https://doi.org/10.1371/journal.pone.0249141 April 1, 2021 17 / 17
